Cargando…
Targeted deletion of Insm2 in mice result in reduced insulin secretion and glucose intolerance
BACKGROUND: Neurogenin3 (Ngn3) and neurogenic differentiation 1 (NeuroD1), two crucial transcriptional factors involved in human diabetes (OMIM: 601724) and islet development, have been previously found to directly target to the E-boxes of the insulinoma-associated 2 (Insm2) gene promoter, thereby a...
Autores principales: | Wang, Lin, Sun, Zhong Sheng, Xiang, Bingwu, Wei, Chi-ju, Wang, Yan, Sun, Kevin, Chen, Guanjie, Lan, Michael S., Carmona, Gilberto N., Notkins, Abner L., Cai, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202866/ https://www.ncbi.nlm.nih.gov/pubmed/30359270 http://dx.doi.org/10.1186/s12967-018-1665-6 |
Ejemplares similares
-
Partial Inhibition of Insulin Secretion Results in Glucose Intolerance but Not Hyperglucagonemia
por: Ramanathan, Ranjani P., et al.
Publicado: (2011) -
Small Molecules Targeting INSM1 for the Treatment of High-Risk Neuroblastoma
por: Lan, Michael S., et al.
Publicado: (2023) -
Insm1a Regulates Motor Neuron Development in Zebrafish
por: Gong, Jie, et al.
Publicado: (2017) -
Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma
por: Chen, Chiachen, et al.
Publicado: (2022) -
INSM1 Expression in Breast Neoplasms with Neuroedocrine Features
por: Metovic, Jasna, et al.
Publicado: (2021)